Search

Home > UpToDate Talk > Guselkumab and tildrakizumab for plaque psoriasis; Two new investigational therapies for hemophilia
Podcast: UpToDate Talk
Episode:

Guselkumab and tildrakizumab for plaque psoriasis; Two new investigational therapies for hemophilia
Category: Science & Medicine
Duration: 00:35:30
Publish Date: 2017-10-04 11:40:14
Description: This episode features Dr. Kristina Callis Duffin discussing the efficacy and safety of guselkumab and tildrakizumab in patients with moderate to severe plaque psoriasis, and Dr. Amy Shapiro discussing emicizumab prophylaxis in hemophilia A with inhibitors and targeting of antithrombin in hemophilia A or B using RNA interference therapy. Dr. Jennifer Tirnauer hosts.
Total Play: 0